FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2795559611> ?p ?o ?g. }

• W2795559611 endingPage "710" @default.
• W2795559611 startingPage "699" @default.
• W2795559611 abstract "Gliomas, the most common primary malignant brain tumor, exhibit high metabolic activity. The targeting of metabolism alterations, particularly in mitochondria, is emerging as an efficient approach for curing cancers. Here, we showed that berberine, a natural compound that is used as an antibacterial agent, could reduce cellular viability and induce oncosis-like death, characterized by cell swelling, cytoplasmic vacuoles and plasma membrane blebbing, in gliomas, and that these effects were correlated with intracellular adenosine triphosphate (ATP) depletion. We also found that berberine induced autophagy as a protective effect and decreased the oxygen consumption rate (OCR), which could inhibit mitochondrial aerobic respiration by repressing phosphorylated extracellular regulated protein kinases (p-ERK1/2). Furthermore, the down-regulation of mitochondrial p-ERK1/2 by berberine inhibited aerobic respiration and led to glycolysis, an inefficient energy production pathway. In addition, berberine reduced tumor growth and inhibited Ki-67 and p-ERK1/2 expression in vivo. The results demonstrate that berberine, which represses aerobic oxidation in mitochondria and decreases their energy production efficiency, decreases metabolic activity by reducing ERK1/2 activity." @default.
• W2795559611 created "2018-04-13" @default.
• W2795559611 creator A5000083563 @default.
• W2795559611 creator A5001311005 @default.
• W2795559611 creator A5022028016 @default.
• W2795559611 creator A5040362491 @default.
• W2795559611 creator A5055005604 @default.
• W2795559611 creator A5066069697 @default.
• W2795559611 creator A5077640505 @default.
• W2795559611 creator A5085245457 @default.
• W2795559611 creator A5085462851 @default.
• W2795559611 date "2018-06-01" @default.
• W2795559611 modified "2023-10-12" @default.
• W2795559611 title "Oncosis-like cell death is induced by berberine through ERK1/2-mediated impairment of mitochondrial aerobic respiration in gliomas" @default.
• W2795559611 cites W1968641535 @default.
• W2795559611 cites W1974447045 @default.
• W2795559611 cites W1996365670 @default.
• W2795559611 cites W1997348190 @default.
• W2795559611 cites W1999816548 @default.
• W2795559611 cites W2005352571 @default.
• W2795559611 cites W2006355482 @default.
• W2795559611 cites W2009141930 @default.
• W2795559611 cites W2011559405 @default.
• W2795559611 cites W2014742651 @default.
• W2795559611 cites W2030363519 @default.
• W2795559611 cites W2030933825 @default.
• W2795559611 cites W2036044314 @default.
• W2795559611 cites W2048899027 @default.
• W2795559611 cites W2065857667 @default.
• W2795559611 cites W2070502658 @default.
• W2795559611 cites W2072663690 @default.
• W2795559611 cites W2101309212 @default.
• W2795559611 cites W2103735571 @default.
• W2795559611 cites W2112026655 @default.
• W2795559611 cites W2129648100 @default.
• W2795559611 cites W2133032371 @default.
• W2795559611 cites W2135793165 @default.
• W2795559611 cites W2157099092 @default.
• W2795559611 cites W2163123432 @default.
• W2795559611 cites W2177430595 @default.
• W2795559611 cites W2291628201 @default.
• W2795559611 cites W2304133322 @default.
• W2795559611 cites W2340897492 @default.
• W2795559611 cites W2346538922 @default.
• W2795559611 cites W2409372173 @default.
• W2795559611 cites W2473591635 @default.
• W2795559611 cites W2555801679 @default.
• W2795559611 cites W2560593836 @default.
• W2795559611 cites W2578122296 @default.
• W2795559611 cites W2587678676 @default.
• W2795559611 cites W2611224317 @default.
• W2795559611 cites W2612668170 @default.
• W2795559611 cites W2625050229 @default.
• W2795559611 cites W2739938272 @default.
• W2795559611 cites W2746036157 @default.
• W2795559611 cites W2746266570 @default.
• W2795559611 cites W2789571287 @default.
• W2795559611 doi "https://doi.org/10.1016/j.biopha.2018.03.132" @default.
• W2795559611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29604589" @default.
• W2795559611 hasPublicationYear "2018" @default.
• W2795559611 type Work @default.
• W2795559611 sameAs 2795559611 @default.
• W2795559611 citedByCount "31" @default.
• W2795559611 countsByYear W27955596112018 @default.
• W2795559611 countsByYear W27955596112019 @default.
• W2795559611 countsByYear W27955596112020 @default.
• W2795559611 countsByYear W27955596112021 @default.
• W2795559611 countsByYear W27955596112022 @default.
• W2795559611 countsByYear W27955596112023 @default.
• W2795559611 crossrefType "journal-article" @default.
• W2795559611 hasAuthorship W2795559611A5000083563 @default.
• W2795559611 hasAuthorship W2795559611A5001311005 @default.
• W2795559611 hasAuthorship W2795559611A5022028016 @default.
• W2795559611 hasAuthorship W2795559611A5040362491 @default.
• W2795559611 hasAuthorship W2795559611A5055005604 @default.
• W2795559611 hasAuthorship W2795559611A5066069697 @default.
• W2795559611 hasAuthorship W2795559611A5077640505 @default.
• W2795559611 hasAuthorship W2795559611A5085245457 @default.
• W2795559611 hasAuthorship W2795559611A5085462851 @default.
• W2795559611 hasConcept C102568950 @default.
• W2795559611 hasConcept C105702510 @default.
• W2795559611 hasConcept C182215343 @default.
• W2795559611 hasConcept C185592680 @default.
• W2795559611 hasConcept C190062978 @default.
• W2795559611 hasConcept C190283241 @default.
• W2795559611 hasConcept C20251656 @default.
• W2795559611 hasConcept C203522944 @default.
• W2795559611 hasConcept C2780116568 @default.
• W2795559611 hasConcept C28406088 @default.
• W2795559611 hasConcept C28859421 @default.
• W2795559611 hasConcept C31573885 @default.
• W2795559611 hasConcept C55493867 @default.
• W2795559611 hasConcept C62231903 @default.
• W2795559611 hasConcept C66517615 @default.
• W2795559611 hasConcept C79879829 @default.
• W2795559611 hasConcept C86803240 @default.
• W2795559611 hasConcept C95444343 @default.
• W2795559611 hasConceptScore W2795559611C102568950 @default.

• next